Clinical data is a goldmine — but Europe’s startups are struggling to grow

• Big Pharma and biotech companies often outsource clinical trials to external companies.
• Startups offer services ranging from clinical trials recruitment to patient monitoring. 
• Europe’s early-stage clinical trials startups are flush with funds but they’re struggling to grow.

When Benevolent AI announced its trial for a new drug to treat eczema had led to “inconclusive results,” it signaled a tough omen for the drug-discovery company. 

Months later, it slashed 180 staffers and paused a drug trial for BEN-2293, its eczema drug, redirecting its capital to other, more promising trials.